ReviewCellular and molecular neurobiology1995
Molecular neurobiology and pharmacology of the vasopressin/oxytocin receptor family.
Review in Cellular and molecular neurobiology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Early response to venlafaxine antidepressant correlates with lower ACTH levels prior to pharmacological treatment.Endocrine · 2006Trial
- The HPA Axis as Target for Depression.Current neuropharmacology · 2024Article
- Sex matters: The impact of oxytocin on healthy conditions and psychiatric disorders.Comprehensive psychoneuroendocrinology · 2023Article
- Targeting the Arginine Vasopressin VNeuropsychiatric disease and treatment · 2023Review
- Vasopressin V1B Receptor Antagonists as Potential Antidepressants.The international journal of neuropsychopharmacology · 2021Review
- Is Oxytocin "Nature's Medicine"?Pharmacological reviews · 2020Review
- Neuroendocrine Mechanisms Involved in Male Sexual and Emotional Behavior.Endocrine, metabolic & immune disorders drug targets · 2019Review
- The Impact of Oxytocin Gene Knockout on Sexual Behavior and Gene Expression Related to Neuroendocrine Systems in the Brain of Female Mice.Cellular and molecular neurobiology · 2017Article
- Examining the Role of Vasopressin in the Modulation of Parental and Sexual Behaviors.Frontiers in psychiatry · 2015Review
- Stress, sex, and addiction: potential roles of corticotropin-releasing factor, oxytocin, and arginine-vasopressin.Behavioural pharmacology · 2014Review
- Article
- The vasopressin Avpr1b receptor: molecular and pharmacological studies.Stress (Amsterdam, Netherlands) · 2011Review
- Vasopressin protects hippocampal neurones in culture against nutrient deprivation or glutamate-induced apoptosis.Journal of neuroendocrinology · 2010Article
- Oxytocin receptors in the primate ovary: molecular identity and link to apoptosis in human granulosa cells.Human reproduction (Oxford, England) · 2010Article
- Anti-apoptotic actions of vasopressin in H32 neurons involve MAP kinase transactivation and Bad phosphorylation.Experimental neurology · 2008Article
- Oxytocin stimulates secretory processes in lactating rabbit mammary epithelial cells.The Journal of physiology · 2006Article
- Science review: Vasopressin and the cardiovascular system part 1--receptor physiology.Critical care (London, England) · 2003Review
- Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue.British journal of cancer · 2003Article
- Vasopressin V1b receptor knockout reduces aggressive behavior in male mice.Molecular psychiatry · 2002Article
- Synaptic control of motoneuronal excitability.Physiological reviews · 2000Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
1. VP and OT mediate their wealth of effects via 4 receptor subtypes V1a, V1b, V2, and OT receptors. 2. We here review recent insights in the pharmacological properties, structure activity relationships, species differences in ligand specificity, expression patterns, and signal transduction of VP/OT receptor. 3. Furthermore, the existence of additional VP/OT receptor subtypes is discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.